Andreas Kronbichler

Medical University of Innsbruck

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (12)

Michael Walsh

Associate Professor

McMaster University

CANADA

View details

Silke R Brix

UNITED KINGDOM

View details

Samira Bell

Academic, Clinical Sen Lecturer/Honorary Cons (Teaching and Research)

University of Dundee

UNITED KINGDOM

View details

Kate I Stevens

UNITED KINGDOM

View details

Rachel Jones

University of Cambridge

UNITED KINGDOM

View details

Raoul Bergner

Head of department

GERMANY

View details

Jose A Gómez-Puerta

Associate Professor

University of Barcelona

SPAIN

View details

Augusto Vaglio

Associate Professor

University of Florence

ITALY

View details

Annette Bruchfeld

Karolinska Institutet

SWEDEN

View details

Marios Papasotiriou

University Hospital of Patras

GREECE

View details

Yann Nguyen

Université Paris-Saclay

FRANCE

View details

Hae Yoon Grace Choung

University of Rochester Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andreas Kronbichler

Research Interests

Explore related searches

Contact this professor

Articles (21)

The authors reply

Long COVID and the kidney

Advances in the treatment of ANCA-associated vasculitis

IgG4-Related Kidney Disease.

Extrarenal “crescent” in multisystem granulomatosis with polyangiitis

Sodium-glucose cotransporter 2 (SGLT2) inhibition and autoimmunity

The Florence Working Group

Does plasma exchange have a role in ANCA-associated vasculitis? Viewpoint 2: plasma exchange may be useful under some circumstances

Highlights from the breakout session: cellular and molecular mechanisms of disease (II)

CRISPR-Cas9 system in autosomal dominant polycystic kidney disease: a comprehensive review

Immunosuppression Withdrawal in Patients with Lupus Nephritis

Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicentre retrospective case-control study

From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies.

Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis.

Response to: Correspondence on ‘Call for action in ANCA-associated vasculitis and lupus nephritis: promises and challenges of SGLT-2 inhibitors’ by Patoulias

Traditional and Disease Specific Risk Factors for Cardiovascular Events in ANCA-Associated Vasculitis: A Multinational Retrospective Study.

Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG).

Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis.

Response to: ‘Correspondence on ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern’’ by Hocevaret al

Avacopan for ANCA-associated vasculitis - information for prescribers.

Management of anti-neutrophil cytoplasmic antibody associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 Guidelines/Recommendations.

Collaborators (12)

Michael Walsh

Silke R Brix

Samira Bell

Kate I Stevens

Rachel Jones

Raoul Bergner

Jose A Gómez-Puerta

Augusto Vaglio

Annette Bruchfeld

Marios Papasotiriou

Yann Nguyen

Hae Yoon Grace Choung

Make your next move.